Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Immune and inflammation

Hormonal

Modifiable Lifestyle Factors

Diet

Laboratory Testing

Blood

Text Availability

Abstract

6321

Full text

5213

Free full text

2782

Publication Types

Journal Article

6398

Research Support, Non-U.S. Gov't

2591

Clinical Trial, Phase II

1886

Randomized Controlled Trial

1713

Multicenter Study

1664

Clinical Trial

1431

Review

1160

Clinical Trial, Phase I

783

Clinical Trial, Phase III

685

Comparative Study

662

Research Support, N.I.H., Extramural

504

Case Reports

206

Observational Study

201

Meta-Analysis

176

Research Support, U.S. Gov't, P.H.S.

166

Systematic Review

144

Letter

Controlled Clinical Trial

Clinical Trial Protocol

Comment

Research Support, U.S. Gov't, Non-P.H.S.

Editorial

Network Meta-Analysis

Evaluation Study

Research Support, N.I.H., Intramural

Equivalence Trial

Validation Study

Clinical Trial, Phase IV

Practice Guideline

News

Video-Audio Media

Pragmatic Clinical Trial

Retracted Publication

Consensus Development Conference

Webcast

Guideline

Congress

Historical Article

Lecture

Interview

Publication Year

From

Quick links

Individual year

2026

2025

229

2024

218

2023

145

2022

230

2021

382

2020

291

2019

270

2018

191

2017

293

2016

240

2015

256

2014

247

2013

276

2012

233

2011

228

2010

253

2009

220

2008

268

2007

258

2006

247

2005

306

2004

285

2003

269

2002

219

2001

250

2000

168

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Antineoplastic Combined Chemotherapy Protocols""[mesh_terms]

6528 Results

Searching titles within these results

Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial.

Francesca Ligorio, Giovanni Fucà, Leonardo Provenzano, Riccardo Lobefaro, Lucrezia Zanenga, Andrea Vingiani, Antonino Belfiore, Alice Lorenzoni, Alessandra Alessi, Giancarlo Pruneri, Filippo de Braud, Claudio Vernieri

European journal of cancer (Oxford, England : 1990) 2022;172():300-310

Full Text

Abstract

Recent advance in phytonanomedicine and mineral nanomedicine delivery system of the treatment for acute myeloid leukemia.

Yimin Jia, Cun Sun, Ting Chen, Hui Zhu, Tianrui Wang, Yan Ye, Xing Luo, Xiaoqiang Zeng, Yun Yang, Hao Zeng, Quanming Zou, Enqiang Liu, Jieping Li, Hongwu Sun

Journal of nanobiotechnology 2023;21(1):240

Free Full Text

Abstract

Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.

Joan Albanell, José Manuel Pérez-García, Miguel Gil-Gil, Giuseppe Curigliano, Manuel Ruíz-Borrego, Laura Comerma, Joan Gibert, Meritxell Bellet, Begoña Bermejo, Lourdes Calvo, Juan de la Haba, Enrique Espinosa, Alessandro Marco Minisini, Vanesa Quiroga, Ana Santaballa Bertran, Leonardo Mina, Beatriz Bellosillo, Federico Rojo, Silvia Menéndez, Miguel Sampayo-Cordero, Crina Popa, Andrea Malfettone, Javier Cortés, Antonio Llombart-Cussac

Clinical cancer research : an official journal of the American Association for Cancer Research 2023;29(1):67-80

Free Full Text

Abstract

Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action.

Peter V Danenberg, Bengt Gustavsson, Patrick Johnston, Per Lindberg, Rudolf Moser, Elisabeth Odin, Godefridus J Peters, Nicholas Petrelli

Critical reviews in oncology/hematology 2017;106():118-31

Free Full Text

Abstract

Smell and Taste Disorders Resulting from Cancer and Chemotherapy.

David G Laing, Claire E Wakefield, Jennifer Cohen

Current pharmaceutical design 2017;22(15):2253-63

Full Text

Abstract

The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?

David H Abramson, Ira J Dunkel, Allison E Rizzuti

Archives of ophthalmology (Chicago, Ill. : 1960) 2008;126(6):862-5

Full Text

HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma.

Toru Nakamura, Tsuyoshi Hayashi, Yasutoshi Kimura, Hiroshi Kawakami, Kuniyuki Takahashi, Hirotoshi Ishiwatari, Takuma Goto, Masayo Motoya, Keisuke Yamakita, Yusuke Sakuhara, Michihiro Ono, Eiichi Tanaka, Makoto Omi, Katsuhiko Murakawa, Tomoya Iida, Tamaki Sakurai, Shin Haba, Takehiro Abiko, Yoichi M Ito, Hiroyuki Maguchi, Satoshi Hirano

Scientific reports 2022;12(1):9966

Free Full Text

Abstract

Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?

Vincenzo Flati, Giovanni Corsetti, Evasio Pasini, Anna Rufo, Claudia Romano, Francesco Saverio Dioguardi

Anti-cancer agents in medicinal chemistry 2016;16(1):89-100

Full Text

Abstract

Anemia in cancer.

M Dicato, L Plawny, M Diederich

Annals of oncology : official journal of the European Society for Medical Oncology 2011;21 Suppl 7():vii167-72

Free Full Text

Abstract

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma.

Kristine A Frerichs, Monique C Minnema, Mark-David Levin, Annemiek Broijl, Gerard M J Bos, Marie José Kersten, Tuna Mutis, Christie P M Verkleij, Inger S Nijhof, Patricia W C Maas-Bosman, Saskia K Klein, Sonja Zweegman, Pieter Sonneveld, Niels W C J van de Donk

Blood advances 2022;5(23):5128-5139

Free Full Text

Abstract

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.

Arndt Vogel, Yajin Chen, Zhenggang Ren, Shukui Qin, Stephen L Chan, Shanzhi Gu, Yuxian Bai, Xiaoyan Lin, Zhendong Chen, Weidong Jia, Yongdong Jin, Yabing Guo, Xiaohua Hu, Zhiqiang Meng, Jun Liang, Ying Cheng, Jianping Xiong, Hong Ren, Fang Yang, Wei Li, Yong Zeng, Alexander Sultanbaev, Monika Pazgan-Simon, Margaryta Pisetska, Davide Melisi, Dmitriy Ponomarenko, Yurii Osypchuk, Ivan Sinielnikov, Tsai-Sheng Yang, Xiao Liang, Chunxia Chen, Linna Wang, Ann-Lii Cheng, Ahmed Kaseb

Lancet (London, England) 2023;402(10408):1133-1146

Full Text

Abstract

Systemic therapy for patients with metastatic pheochromocytoma and paraganglioma.

Jaydira Del Rivero, Camilo Jimenez, Katharina Wang, Svenja Nölting, Alessa Fischer

Best practice & research. Clinical endocrinology & metabolism 2025;39(1):101977

Full Text

Abstract

Dual targeting of tumor cell energy metabolism and lysosomes as an anticancer strategy.

Verica Paunovic, Milica Kosic, Maja Misirkic-Marjanovic, Vladimir Trajkovic, Ljubica Harhaji-Trajkovic

Biochimica et biophysica acta. Molecular cell research 2021;1868(4):118944

Free Full Text

Abstract

The use of antioxidant therapies during chemotherapy.

Jeanne A Drisko, Julia Chapman, Verda J Hunter

Gynecologic oncology 2003;88(3):434-9

Full Text

Abstract

Drug-induced amino acid deprivation as strategy for cancer therapy.

Marcus Kwong Lam Fung, Godfrey Chi-Fung Chan

Journal of hematology & oncology 2018;10(1):144

Free Full Text

Abstract

Results: 1 – 15 / 6528

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Laboratory Testing

Text Availability

Publication Types

Publication Year

Results for ""Antineoplastic Combined Chemotherapy Protocols""[mesh_terms]

Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial.

Recent advance in phytonanomedicine and mineral nanomedicine delivery system of the treatment for acute myeloid leukemia.

Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.

Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action.

Smell and Taste Disorders Resulting from Cancer and Chemotherapy.

The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?

HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma.

Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?

Anemia in cancer.

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma.

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.

Systemic therapy for patients with metastatic pheochromocytoma and paraganglioma.

Dual targeting of tumor cell energy metabolism and lysosomes as an anticancer strategy.

The use of antioxidant therapies during chemotherapy.

Drug-induced amino acid deprivation as strategy for cancer therapy.

Results for

""Antineoplastic Combined Chemotherapy Protocols""[mesh_terms]